Get the Stockscreener App
9.92
0.20%
0.02
After Hours:
9.92
Daxor Corporation stock is traded at $9.92, with a volume of 4,478.
It is up +0.20% in the last 24 hours and up +1.33% over the past month.
Daxor Corporation, a medical device company, provides biotechnology and cryobanking services in the United States. The company offers BVA-100 Blood Volume Analyzer, an instrument that measures blood volume in human body. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients in various medical and surgical conditions, including congestive heart failure, critical care medicine and intensive care unit medicine, hypertension, syncope, pre-operative blood screening for hidden anemia, anemia in cancer patients, kidney failure, and hyponatremia. It also provides semen banking, blood storage, andrology, and general lab testing services. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
See More
Previous Close:
$9.90
Open:
$10.08
24h Volume:
4,478
Relative Volume:
0.97
Market Cap:
$47.98M
Revenue:
$2.61M
Net Income/Loss:
$1.69M
P/E Ratio:
33.03
EPS:
0.3003
Net Cash Flow:
-
1W Performance:
-0.80%
1M Performance:
+1.33%
6M Performance:
+29.08%
1Y Performance:
+12.28%
1-Day Range:
$9.75
$10.30
1-Week Range:
$9.10
$10.49
52-Week Range:
$6.55
$10.49
Daxor Corporation Stock (DXR) Company Profile
Name
Daxor Corporation
Sector
Industry
Phone
212-330-8500
Address
Empire State Building, Suite 7120 350 Fifth Avenue, New York, NY
Compare DXR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DXR
Daxor Corporation
|
9.92 | 49.13M | 2.61M | 1.69M | 0 | 0.3003 |
|
ISRG
Intuitive Surgical Inc
|
481.09 | 179.42B | 9.15B | 2.61B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
178.25 | 52.03B | 20.87B | 1.50B | 2.59B | 5.24 |
|
ALC
Alcon Inc
|
87.55 | 44.11B | 9.93B | 1.12B | 1.58B | 2.25 |
|
RMD
Resmed Inc
|
271.94 | 40.68B | 5.02B | 1.31B | 1.56B | 8.91 |
|
WST
West Pharmaceutical Services Inc
|
239.26 | 17.92B | 2.90B | 467.20M | 306.90M | 6.37 |
Daxor Corporation Stock (DXR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-16-19 | Initiated | Ascendiant Capital Markets | Buy |
Daxor Corporation Stock (DXR) Latest News
Should I hold or sell Daxor Corporation stock in 2025Wealth Building Trend Scanner For Smart Trading - jammulinksnews.com
Will Daxor Corporation continue its uptrendWeekly Price Target Forecast and Alerts - Newser
How high can Daxor Corporation stock price go in 2025Strong Buy Signal Summary with Entry Zone - Newser
How Daxor Corporation stock performs during market volatilityValue Investing Checklist with Entry Signals - Newser
Moving Average Trends for Daxor Corporation Stock: What They IndicateFree Fast Return Equity Trade Forecast - Newser
What makes Daxor Corporation stock price move sharplyFree Consistent Income Focused Trade List - Newser
Is Daxor Corporation forming a bottoming baseFree Opportunity Map for Daily Stock Trading - Newser
Top chart patterns to watch in Daxor CorporationEntry Confirmation Using Short-Term Forecasting - Newser
Why Daxor Corporation stock attracts strong analyst attentionDaily Market Momentum Summary and Strategy - Newser
Daxor Corporation Stock Chart Analysis: Bullish or Bearish Pattern FormingBreakout Screener With Alert Based Timing - Newser
Measuring Daxor Corporation’s beta against major indicesShort Term Gain Strategy with AI Logic - Newser
Is Daxor Corporation a growth stock or a value stockRecord-breaking capital gains - jammulinksnews.com
Will Daxor Corporation continue its uptrend Long Term Stock Planner with Safety Checks - Newser
Will Daxor Corporation continue its uptrend High Probability Trade Outcome Prediction - Newser
How does Daxor Corporation generate profit in a changing economySuperior profit margins - jammulinksnews.com
What are Daxor Corporation company’s key revenue driversCapitalize on momentum-driven opportunities - jammulinksnews.com
What is Daxor Corporation company’s growth strategyAchieve rapid portfolio growth with expert guidance - jammulinksnews.com
What are the latest earnings results for Daxor CorporationMarket-leading growth rates - jammulinksnews.com
What is the dividend policy of Daxor Corporation stockMaximize gains with strategic stock entries - jammulinksnews.com
What markets is FACTW expanding into Is Daxor Corporation stock a good long term investment option - jammulinksnews.com
Daxor Corporation Earnings Report Breakdown: What Investors Should KnowFree Smart Investment Opportunities - Newser
What analysts say about Daxor Corporation stockSuperior risk-adjusted returns - PrintWeekIndia
Is Daxor Corporation a good long term investmentFree Stock Selection - Autocar Professional
Daxor Corporation Stock Analysis and ForecastMarket-leading capital gains - jammulinksnews.com
What drives Daxor Corporation stock priceDynamic growth stocks - jammulinksnews.com
Daxor's Blood Volume Analysis Technology Accelerates Market Pene - GuruFocus
Daxor (DXR) Expands Blood Volume Analysis Technology in New Hosp - GuruFocus
Daxor’s Blood Volume Analysis Technology Accelerates Market Penetration with Three New Facility Adoptions - GlobeNewswire
Daxor Expands Blood Volume Analysis Technology to 3 Major Heart Care Centers Across US - Stock Titan
Spectral AI Inc. Stock Analysis and ForecastFree Risk Assessment Services - jammulinksnews.com
Daxor Corporation Stock (DXR) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.22%
22.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):